SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001047469-99-016759
Filing Date
1999-04-28
Accepted
1999-04-28 00:00:00
Documents
1
Group Members
ALMANORI LTDAXA U.S. GROWTH FUND, LLCDOUBLE BLACK DIAMOND II, LLCMULTINVEST LIMITEDPARTECH INTERNATIONAL SALARYPARVEST U.S. PARTNERS II C.V.THOMAS G. MCKINLEYTRADEINVEST LIMITEDU.S. GROWTH FUND PARTNERS C.V.VINCENT R. WORMS

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G/A SC 13G/A 33012
  Complete submission text file 0001047469-99-016759.txt   35122
Mailing Address 3832 BAY CENTER PLACE HAYWARD CA 94545
Business Address 3832 BAY CENTER PL HAYWARD CA 94545 5106709300
LYNX THERAPEUTICS INC (Subject) CIK: 0000913275 (see all company filings)

IRS No.: 943161073 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-45671 | Film No.: 99602974
SIC: 2833 Medicinal Chemicals & Botanical Products

Mailing Address
Business Address P O BOX 711 ROAD TOWN TORTOLA BRITISH VIRGIN ISLS D8 00000
ALMANORI LTD (Filed by) CIK: 0001041113 (see all company filings)